Article info
PDFOriginal article
Measuring response to neoadjuvant chemotherapy in high-grade serous tubo-ovarian carcinoma: an analysis of the correlation between CT imaging and chemotherapy response score
- Correspondence to Dr Meabh McNulty, Medical Oncology, St John of God Hospital Bendat Family Comprehensive Cancer Centre, Subiaco, WA 6008, Australia; meabh23{at}gmail.com
Citation
Measuring response to neoadjuvant chemotherapy in high-grade serous tubo-ovarian carcinoma: an analysis of the correlation between CT imaging and chemotherapy response score
Publication history
- Received January 9, 2019
- Revision received March 13, 2019
- Accepted April 2, 2019
- First published May 15, 2019.
Article Versions
- You are currently viewing a Previous version of this article (2 June 2019).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.